QR Code for Endoscopic Bowel Preparation

Exclusion Criteria

• •• Pregnancy or lactating
• •* Lower gastrointestinal bleeding with hemodynamic instability
• •* Bowel obstruction
• •* ASA \>3
• •* Not sufficiently corrected anticoagulation disorders
• •* Plenvu must not be taken:
• •* if you are allergic (hypersensitive) to the active ingredients or any of the other ingredients of this medicine;
• •* if you have a blockage (obstruction) in the digestive tract.
• •* if you have a breakthrough (perforation) in the wall of the digestive tract;
• •* if you suffer from intestinal obstruction (Ileus);
• •* if you suffer from a disturbance of gastric emptying (e.g. gastroparesis, gastric retention);
• •* if you suffer from phenylketonuria. Phenylketonuria is a congenital metabolic disease in which phenylalanine cannot be processed by your body. Plenvu contains aspartame as a source of phenylalanine;
• •* if you suffer from glucose-6-phosphate dehydrogenase deficiency;
• •* if you suffer from acute colon enlargement (toxic megacolon).
• •* Warnings and precautions
• •o You should tell your doctor about the following circumstances before taking Plenvu:
• •* if you have heart problems and/or arrhythmias;
• •* if you have kidney problems and/or suffer from dehydration;
• •* if you have stomach or intestinal problems, including intestinal inflammation;
• •* if you have difficulty or discomfort when swallowing liquids;
• •* if you have high or low levels of electrolyte (e.g. sodium, potassium);
• •* if you have other diseases (e.g. convulsions).
• •* Pregnancy and lactation o There are no data on the use of Plenvu during pregnancy or lactation and is therefore not recommended.